Orient EuroPharma (OEP) acquires a stake in Quantum Genomics

As a follow-up to the agreement signed last September, OEP acquired a minority stake in the capital of Quantum Genomics, thus strengthening the cooperation between the two companies.

Read the press realease

Leave a Reply

Your email address will not be published.